BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 12/12/2025

FDA Clears ZANTAC Injection for Sale Despite Nitrosamine Concerns

The FDA has determined that ZANTAC (ranitidine hydrochloride) injection, equivalent to 25 milligrams base/milliliter, can be manufactured or formulated to meet acceptable intake limits for nitrosamine impurities, allowing it to remain on the market.

Source: Federal Register — Food and Drug AdministrationOpen original release →